Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
about
Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological ImplicationsEstrogen or estrogen receptor agonist inhibits lipopolysaccharide induced microglial activation and deathGenistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties.Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies.Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activationFoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.Diabetes mellitus: channeling care through cellular discoveryNeuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopauseEarly apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Female reproductive factors and primary open-angle glaucoma in the Nurses' Health StudyErythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.Selective estrogen receptor modulators regulate dendritic spine plasticity in the hippocampus of male ratsSelective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemiaMale/Female differences in neuroprotection and neuromodulation of brain dopamineProteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis.17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice.Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States.Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.Estradiol promotes proliferation of dopaminergic precursors resulting in a higher proportion of dopamine neurons derived from mouse embryonic stem cells.The vitamin nicotinamide: translating nutrition into clinical care.Progesterone increases dopamine neurone number in differentiating mouse embryonic stem cells.Estrogen partially down-regulates PTEN to prevent apoptosis in VSC4.1 motoneurons following exposure to IFN-gamma.Neuroprotective actions of selective estrogen receptor modulators.Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.Oestrogens as modulators of neuronal signalosomes and brain lipid homeostasis related to protection against neurodegeneration.Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.N-cadherin is a novel ERα anchor that protects against 6-OHDA damage to dopaminergic cells.Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system.Steroid and Xenobiotic Receptor Signalling in Apoptosis and Autophagy of the Nervous System.Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry
P2860
Q28074448-C2559B3B-0ECA-46C7-9829-10C3F2AD4F03Q28577434-213724E9-2F4B-4D54-9694-3778363E8685Q30418168-97389686-7FA4-424D-AECC-6CEFD095BB8FQ30474007-91A36A73-6AB7-4FF2-BC88-5A715ABFAB48Q30475350-BD03A393-CFA4-4E92-A720-FF3BF5A4A123Q30478476-B4C1685D-D6FB-4E66-947A-2D88C001BFB5Q33436267-2C2174E8-AED8-40AA-8AE4-1E980BE5E70DQ33595388-18432A76-5824-4B6B-8903-BFC5B550995BQ33604706-48444B79-E733-4EDD-81FD-87E05E180599Q33749358-9DFB4029-EA93-4191-A853-767BDB506100Q33762953-A037B6C4-13B9-4C8E-A1B4-9DAD0853630DQ33877687-52543122-1C27-46EA-9883-3E128F3BA3FFQ34185844-0C540478-B694-42B7-9FDB-4A76A70FF97CQ34552287-5D6C091C-D1BE-442F-BDBE-952D4A7E4D22Q34977665-8D63EC01-1CAA-4A22-B611-7E94177F84EBQ35146283-34726381-ABEF-4E48-B33E-C6F1DBA659D4Q35550876-762370E8-7B75-4313-A02A-200B28F8AA12Q35569533-B82F937E-3C17-4764-91C1-CFC7AE45ED42Q35972056-E9502D40-229E-4204-939A-E3C2539C950DQ36089898-1AC6964B-3F84-432C-8EC3-9DD70EA52EB2Q36442883-E7B0199B-B1B4-45BF-86F6-53B2EFF69FCCQ37016927-234E4EA6-F0B6-44A6-9920-EF3D5FD7D053Q37088442-FB38E1CD-CFE0-4ED2-B30F-D26314C2D9E3Q37372570-FB1E23C0-6F31-49FB-ABF6-ED1A3D62CE52Q37374047-B33AEA18-44E2-42E5-A389-EE2FB931E662Q37390372-9E6383F1-170E-4807-8CEA-CBB6A16C7F81Q37442718-849CDC53-1BED-4D33-8115-C8D333C5EBFDQ37479919-B43B6E0F-2355-4FD3-863D-109CD0D98F75Q37874684-E17ED85D-774F-4A74-A928-0B5C436D5D90Q38116551-164A8D02-4B6E-4D33-8252-FF16E7B52964Q38837641-A6246727-5576-449C-B74A-83485E51BA32Q39061178-2D875C94-5D63-40E1-9763-E71D7641CCD7Q42361824-A0CB824A-DF80-430E-B1A9-126CE7CAF2C1Q47129713-DC5A42EB-7EA0-420E-9CB5-0FFA311F0359Q50890383-1A91B142-51BB-44E9-B9E0-DC7860824C21Q58704396-35B9F941-7FEB-4965-AC62-C5B2C7063954
P2860
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@en
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@nl
type
label
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@en
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@nl
prefLabel
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@en
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@nl
P50
P1476
Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
@en
P356
10.1016/J.MCE.2008.04.008
P4011
f8635174f68ee509ca98ca5fc6a86eec5b0dc436
P407
P577
2008-04-22T00:00:00Z